FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL | FDA News
For Immediate Release: July 24, 2020 Today, the U.S. Food and Drug Administration approved Tecartus (brexucabtagene autoleucel), a cell-based gene therapy for treatment of adult patients diagnosed with mantle cell…